Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Testing the Safety and Efficacy of the Combination of the Antibody Pembrolizumab and Entinostat in Patients With Myelodysplastic Syndrome Who Are Not Responding to Hypomethylating Agents
- Status
- COMPLETED
- Phase
- PHASE1
Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
- Status
- COMPLETED
- Phase
- PHASE1
Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study
- Status
- COMPLETED
- Phase
- NA
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
- Status
- TERMINATED
- Phase
- PHASE2
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT
- Status
- UNKNOWN
- Phase
- N/A
A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls
- Status
- COMPLETED
- Phase
- NA
A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE1
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
- Status
- COMPLETED
- Phase
- N/A
Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1